Matthew T. Roe

Active 1996–2025

Also published as
Matthew T Roe
177
Papers
33,827
Citations
103
h-index
176
i10-index

Citations

Citations per year for Matthew T. Roe1952: 1 citations1969: 1 citations1995: 2 citations1996: 1 citations1997: 1 citations1998: 4 citations1999: 4 citations2000: 8 citations2001: 13 citations2002: 23 citations2003: 29 citations2004: 30 citations2005: 65 citations2006: 67 citations2007: 131 citations2008: 110 citations2009: 135 citations2010: 158 citations2011: 237 citations2012: 216 citations2013: 222 citations2014: 259 citations2015: 211 citations2016: 190 citations2017: 186 citations2018: 201 citations2019: 1,024 citations2020: 1,201 citations2021: 1,058 citations2022: 896 citations2023: 663 citations2024: 1,171 citations2025: 532 citations2026: 41 citations1953–1968: no citations, so these years are not shown1970–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,484 citing papers, 23.8% of this breakdownUnited Kingdom: 1,181 citing papers, 8.1% of this breakdownCanada: 854 citing papers, 5.8% of this breakdownItaly: 802 citing papers, 5.5% of this breakdownChina: 727 citing papers, 5% of this breakdownGermany: 692 citing papers, 4.7% of this breakdownFrance: 515 citing papers, 3.5% of this breakdownNetherlands: 492 citing papers, 3.4% of this breakdownAustralia: 475 citing papers, 3.2% of this breakdownSpain: 408 citing papers, 2.8% of this breakdownSweden: 316 citing papers, 2.2% of this breakdownJapan: 304 citing papers, 2.1% of this breakdown
0%23.8%Other 29.9%

Fields

  • Medicine86.4%
  • Biochemistry, Genetics and Molecular Biology3.8%
  • Health Professions2.6%
  • Engineering1.7%
  • Economics, Econometrics and Finance1.2%
  • Computer Science1.1%
  • Other3.2%

Topics

  • Lipoproteins and Cardiovascular Health8.2%
  • Acute Myocardial Infarction Research7.8%
  • Coronary Interventions and Diagnostics4.5%
  • Diabetes Treatment and Management4.4%
  • Cardiac Imaging and Diagnostics4.1%
  • Antiplatelet Therapy and Cardiovascular Diseases3.9%
  • Other67.1%

Coauthors

All papers

Open in search
  1. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 3,519

  2. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David C. M. Kong, Gerald S. Bloomfield, Matthew T. Roe, Pierluigi Tricoci, Robert W. Harrison, Renato D. Lópes, Robin Mathews, Rajendra Mehta, W. Schuyler Jones, Sreekanth Vemulapalli, Thomas J. Povsic, Zubin J. Eapen, Keith Dombrowski, Brad J. Kolls, J. Dedrick Jordan, Andrew P. Ambrosy, Stephen J. Greene, Aditya Mandawat, Jay Shavadia, Lauren B. Cooper, Abhinav Sharma, Patrícia O. Guimarães, Daniel J. Friedman, Matthew E. Wilson, Patricia Endsley, Tracy Gentry, Jeannie Collier, Kathleen Perez, K.E. James, Jennifer Roush, C. ARDEN III POPE, Christina Howell, Megan Johnson, M. Bailey, Joanna Cole, Teresa Akers, Beth Vandyne, Betsy Thomas, Jenny Rich, Susan Bartone, Gail Beaulieu, Kim Brown, Tuan Chau, Tamra Christian, Rebecca Coker, Deb Greene, Trevorlyn Haddock, Wendy Jenkins, Ghazala Haque, Marsha L. Marquess, Jean Pesarchick, Renee Rethaford, Allegra Stone, Firas Al- Kawas, Michelle A. Anderson, Robert Enns, Isaac Sinay, Chantal Mathieu, Victor Yordanov, Irene Hramiak, Martin Haluzı́k, Søren Galatius, Bruno Guerci, Michael A. Nauck, Ilias Migdalis, Choon Beng Kathryn Tan, Győző Kocsis, Andrea Giaccari, Moon Kyu Lee, Ernesto Muñoz and 708 more - The Lancet 2018 cited by 1,791

  3. Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2020 cited by 572

  4. The role of machine learning in clinical research: transforming the future of evidence generation

    Authors: , , , , , , , , , , , , , , , , , , , , - Trials 2021 cited by 282

  5. Using Digital Health Technology to Better Generate Evidence and Deliver Evidence-Based Care

    Authors: , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2018 cited by 344

  6. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert A. Harrington, J. Wouter Jukema, Michael Szarek, Harvey D. White, Andreas M. Zeiher, Pierluigi Tricoci, Matthew T. Roe, Kenneth W. Mahaffey, Jay M. Edelberg, Corinne Hanotin, Guillaume Lecorps, Angèle Moryusef, Robert Pordy, William J. Sasiela, Jean‐François Tamby, Philip E. Aylward, Heinz Drexel, Peter Sinnaeve, Mirza Dilić, Renato D. Lópes, Nina Gotcheva, Juan Carlos Prieto, Yong Huo, Patricio López‐Jaramillo, Ivan Pećin, Željko Reiner, Petr Ostadal, Margus Viigimaa, Markku S. Nieminen, Vakhtang Chumburidze, Nikolaus Marx, Nicolas Danchin, Evangelos Liberopoulos, Pablo Carlos Montenegro Valdovinos, Hung‐Fat Tse, Róbert Gábor Kiss, Denis Xavier, Doron Zahger, Marco Valgimigli, Takeshi Kimura, Hyo Soo Kim, Sang‐Hyun Kim, Andrejs Ērglis, Aleksandras Laucevičius, Saško Kedev, K. Yusoff, Gabriel Arturo Ramos López, Marco Alings, Sigrun Halvorsen, Roger M. Correa Flores, Andrzej Budaj, Joao Morais, Maria Dorobantu, Yuri Karpov, Arsen Ristić, Terrance Chua, Jan Murin, Zlatko Fras, Anthony J. Dalby, José Tuñón, H Asita de Silva, Emil Hagström, Ulf Landmesser, Chern‐En Chiang, Piyamitr Sritara, Sema Güneri, Alexander Parkhomenko, Kausik K. Ray, Patrick M. Moriarty, Robert A. Vogel and 1,603 more - The Lancet Diabetes & Endocrinology 2019 cited by 328

  7. Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome

    Authors: , , , , , , , , , , , - Circulation 2020 cited by 187

  8. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tamar S. Polonsky, Dan J. Fintel, Faraz S. Ahmad, James C. McClay, James R. Campbell, Douglas S. Bell, Gregg C. Fonarow, Steven M. Bradley, Anuradha Paranjape, Matthew T. Roe, Holly R. Robertson, Lesley H. Curtis, Amber Sharlow, Lisa G. Berdan, Bradley G. Hammill, Debra F. Harris, Laura G. Qualls, Guillaume Marquis‐Gravel, Madelaine Faulkner Modrow, Gregory M. Marcus, Thomas W. Carton, Elizabeth Nauman, Lemuel R. Waitman, Abel Kho, Elizabeth Shenkman, Kathleen M. McTigue, Rainu Kaushal, Frederick A. Masoudi, Elliott M. Antman, Desiree R. Davidson, Kevin Edgley, J. Greg Merritt, Linda S. Brown, Doris N. Zemon, Thomas E. McCormick, Jacqueline D. Alikhaani, Kenneth C. Gregoire, Russell L. Rothman, Robert A. Harrington, Adrian F. Hernandez - New England Journal of Medicine 2021 cited by 307

  9. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jay M. Edelberg, Corinne Hanotin, Guillaume Lecorps, Angèle Moryusef, Robert Pordy, William J. Sasiela, Jean‐François Tamby, Rafael Diaz, Philip E. Aylward, Heinz Drexel, Peter Sinnaeve, Mirza Dilić, Renato D. Lopes, Nina Gotcheva, Shaun G. Goodman, Juan-Carlos Prieto, Yong Huo, Patricio López‐Jaramillo, Ivan Pećin, Zeljko Reiner, Petr Ošťádal, Steen Hvitfeldt Poulsen, Margus Viigimaa, Markku S. Nieminen, Nicolas Danchin, Vakhtang Chumburidze, Nikolaus Marx, Evangelos Liberopoulos, Pablo Carlos Montenegro Valdovinos, Hung-Fat Tse, Róbert Gábor Kiss, Denis Xavier, Doron Zahger, Marco Valgimigli, Takeshi Kimura, Hyo Soo Kim, Sang-Hyun Kim, Andrejs Ērglis, Aleksandras Laucevičius, Saško Kedev, Khalid Yusoff, Gabriel Arturo Ramos López, Marco Alings, Harvey D. White, Sigrun Halvorsen, Roger M. Correa Flores, Rody G. Sy, Andrzej Budaj, Joao Morais, Maria Dorobantu, Yuri Karpov, Arsen D. Ristic, Terrance Chua, Jan Murin, Zlatko Fras, Anthony J. Dalby, José Tuñón, H. Asita de Silva, Emil Hagström, Ulf Landmesser, Christian Müller, Chern‐En Chiang, Piyamitr Sritara, Sema Güneri, Alexander Parkhomenko, Kausik K. Ray, Patrick M. Moriarty, Matthew T. Roe, Robert A. Vogel, Bernard Chaitman and 1,652 more - Journal of the American College of Cardiology 2021 cited by 141

  10. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew T. Roe, Kenneth W. Mahaffey, Jay M. Edelberg, Corinne Hanotin, Guillaume Lecorps, Angèle Moryusef, Robert Pordy, William J. Sasiela, Jean‐François Tamby, Rafael Díaz, Philip E Aylward, Heinz Drexel, Peter Sinnaeve, Mirza Dilić, Renato D. Lópes, Nina N Gotcheva, Shaun G. Goodman, Juan Carlos Prieto, Huo Yong, Patricio López‐Jaramillo, Ivan Pećin, Zeljko Reiner, Petr Ostadal, Steen Hvitfeldt Poulsen, Margus Viigimaa, Markku S. Nieminen, Nicolas Danchin, Vakhtang Chumburidze, Nikolaus Marx, Evangelos Liberopoulos, Pablo Carlos, Montenegro Valdovinos, Hung‐Fat Tse, Róbert Gábor Kiss, Denis Xavier, Doron Zahger, Marco Valgimigli, Takeshi Kimura, Hyo-Soo Kim, Sang‐Hyun Kim, Andrejs Ērglis, Aleksandras Laucevičius, Saško Kedev, Khalid Yusoff, Gabriel Arturo Ramos López, Marco Alings, Harvey D. White, Sigrun Halvorsen, Roger M Correa Flores, Rody G. Sy, Andrzej Budaj, João Morais, Maria Dorobantu, Yuri Karpov, Arsen Ristić, Terrance Chua, Ján Murín, Zlatko Fras, Anthony J. Dalby, José Tuñón, H. Asita de Silva, Emil Hagström, Ulf Landmesser, Christian Müller, Chern‐En Chiang, Piyamitr Sritara, Sema Güneri, Alexander Parkhomenko, Kausik K. Ray, Patrick M. Moriarty and 1,635 more - Circulation 2022 cited by 122

  11. Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry–GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With the Guidelines)

    Authors: , , , , , , - Circulation Cardiovascular Quality and Outcomes 2017 cited by 343

  12. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2019 cited by 237

  13. Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas J. Povsic, Michael Morse, Kenneth W. Mahaffey, Susan Halabi, Darryl P. Leong, Laurence Klotz, Neil Fleshner, G. Kenneth Jansz, Jonathan Giddens, R. Blair Egerdie, Joseph L. Chin, Joseph Zadra, Richard Casey, Jean Simard, Tamim Niazi, André‐Guy Martin, Marek Babjuk, Jaroslav Hájek, Jiří Klečka, Jiří Kubeš, Jan Schraml, Jitka Jakesova, J Vaňásek, Bohuslav Melichar, Heikki Seikkula, M. Abdiche, Marc Colombel, P. Debourdeau, G. Robert, Arnauld Villers, Guillaume Ploussard, Benjamin Pradère, F. Bruyère, Jean‐Luc Descotes, Idir Ouzaïd, Alexander Winter, Herbert Hanitzsch, H. Sperling, Ralf Eckert, Peter Hammerer, E. Stagge, F. Seseke, Silvio Szymula, Aristotelis Bamias, A. Thanos, Konstantinos Hatzimouratidis, Charalambos Mamoulakis, Haralabos P. Kalofonos, Elżbieta Oszukowska, Katarzyna Madziarska, Jacek Fijuth, Mateusz Obarzanowski, B. Yа. Alekseev, Vagif Atduev, Dmitri Pushkar, Evgeniy Veliev, A. V. Zyryаnov, С Б Петров, Evgeny Kopyltsov, Vadim Kozlov, Ladislav Macko, J. Dúbravický, Richard Polak, Obaidullah Mir, Marek Vargovcak, I. Minčík, J. Kliment, Frederico Gonçalves, J Mikuláš, Roman Sokol and 55 more - Circulation 2021 cited by 143

  14. Risk Factor Burden and Long‐Term Prognosis of Patients With Premature Coronary Artery Disease

    Authors: , , , , , , , , , - Journal of the American Heart Association 2020 cited by 161

  15. Targeting Vascular Calcification in Chronic Kidney Disease

    Authors: , , , , , - JACC Basic to Translational Science 2020 cited by 156

  16. Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction

    Authors: , , , , , , , , , , , , - Circulation 2009 cited by 991

  17. Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES

    Authors: , , , , , , , , , , , , , , , , , , - Circulation 2019 cited by 130

  18. Study Design and Rationale of EXPLORER-HCM

    Authors: , , , , , , , , , - Circulation Heart Failure 2020 cited by 85

  19. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Circulation Cardiovascular Genetics 2016 cited by 226

  20. Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus

    Authors: , , , , , , , , , , , , , , , , , , , , - Circulation 2020 cited by 108

  21. Cardiovascular Drug Development

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2015 cited by 204

  22. Long-Term Mortality of Patients Undergoing Cardiac Catheterization for ST-Elevation and Non-ST-Elevation Myocardial Infarction

    Authors: , , , , , , , , - Circulation 2009 cited by 253

  23. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2018 cited by 172

  24. Comparative Efficacy and Safety of Oral P2Y 12 Inhibitors in Acute Coronary Syndrome

    Authors: , , , , , , , , , , , , , , - Circulation 2020 cited by 141